Trusted by industry leaders
Lead with data-driven decisions
Healthcare services and technology
Seniors housing and skilled nursing
Providing context and analysis on healthcare transactions backed by a 33,000+ deal database
30+ years of expert analysis and unique transaction data sourced directly from market participants
Lead with data-driven decisions
Health care services and technology
Providing context and analysis on healthcare transactions backed by a 31,000+ deal database
Seniors housing and skilled nursing
30+ years of expert analysis and unique transaction data sourced directly from market participants
Built to purpose so you can build your strategy
16 primary sectors
Covering seniors housing, skilled nursing, active adults, CCRC’s, and 12 key healthcare sectors
37,500+ deals
Comprehensive deal database updated daily
LevinPro LTC
Access all long-term care analyst coverage and data
LevinPro HC
Access all healthcare analyst coverage and data
Latest News
-
https://healthcare.levinassociates.com/?p=120611
Highbridge Capital Management, based in New York City, announced on March 27 that it entered into an agreement to acquire Gamida Cell, an Israeli biotechnology company. The agreement will... Read more
-
American Oncology Network Partners With Woodlands Cancer Institute
The American Oncology Network (AON) announced on March 26 the addition of Woodlands Cancer Institute and its physicians to its network. Woodlands Cancer Institute is AON’s second practice in Texas... Read more
-
https://healthcare.levinassociates.com/?p=120611
Highbridge Capital Management, based in New York City, announced on March 27 that it entered into an agreement to acquire Gamida Cell, an Israeli biotechnology company. The agreement will... Read more
-
American Oncology Network Partners With Woodlands Cancer Institute
The American Oncology Network (AON) announced on March 26 the addition of Woodlands Cancer Institute and its physicians to its network. Woodlands Cancer Institute is AON’s second practice in Texas... Read more
Upcoming Webinar
April 18, 2024 | 1:00PM EST
1st Quarter Investor Call